Who will acquire 23andMe?
54
1.8kṀ6431
Dec 31
88%
Anne Wojcicki
22%
Regeneron
12%
Hypera Pharma
11%
Roche
9%
Merck
9%
Johnson & Johnson
9%
Novartis
6%
Pfizer
5%
Eli Lilly
5%
Elon Musk

  • Update 2025-07-03 (PST) (AI summary of creator comment): In the event that 23andMe's assets are acquired by TTAM Research Institute, the market will resolve to Anne Wojcicki.

Get
Ṁ1,000
to start trading!
© Manifold Markets, Inc.TermsPrivacy